中华围产医学杂志
中華圍產醫學雜誌
중화위산의학잡지
CHINESE JOURNAL OF PERINATAL MEDICINE
2014年
11期
729-732
,共4页
祝菁%杨祖菁%王俊%王磊%王蓓
祝菁%楊祖菁%王俊%王磊%王蓓
축정%양조정%왕준%왕뢰%왕배
十二指肠梗阻%超声检查,产前%存活率%预后
十二指腸梗阻%超聲檢查,產前%存活率%預後
십이지장경조%초성검사,산전%존활솔%예후
Duodenal obstruction%Ultrasonography,prenatal%Survival rate%Prognosis
目的 探讨产前超声显示腹部“双泡征”胎儿的围产结局及影响其预后的因素.方法 2000年1月1日至201 3年12月31日,57例孕妇于上海交通大学医学院附属新华医院产前超声检查诊断胎儿“双泡征”,回顾性分析这些胎儿的病历资料及围产结局.新生儿存活≥42 d者(38例)作为存活组,新生儿存活不足42 d者(11例)作为死亡组.采用t检验、x2检验、Fisher精确概率法及Logistic回归模型分析预后不良的影响因素. 结果 (1)产前超声诊断“双泡征”胎儿羊水过多发生率为88%(50/57),胎死宫内发生率为4%(2/57),合并畸形发生率为23%(13/57).8例引产终止妊娠,其余49例活产分娩.49例活产新生儿中10例放弃治疗,另外39例接受手术治疗,1例术后死亡,其余38例存活≥42 d.生后42 d总体存活率为67%(38/57),手术存活率为97%(38/39).(2)死亡组新生儿的出生胎龄和出生体重分别为(35.8±3.0)周和(2 229±567)g,均小于存活组新生儿[分别为(38.1±1.9)周和(2 830±558)g,f值分别为2.859和3.136,P值均<0.01].死亡组新生儿产前诊断合并畸形发生率及生后诊断染色体异常发生率均为3、11,均高于存活组新生儿[均为3%(1/38),P值均<0.05].(3)“双泡征”胎儿合并FGR时,合并畸形的风险较高(OR=9.893, 95%CI:1.758~55.661,P=0.009). 结论 “双泡征”胎儿发生早产、低出生体重、合并畸形和染色体异常者预后不良.
目的 探討產前超聲顯示腹部“雙泡徵”胎兒的圍產結跼及影響其預後的因素.方法 2000年1月1日至201 3年12月31日,57例孕婦于上海交通大學醫學院附屬新華醫院產前超聲檢查診斷胎兒“雙泡徵”,迴顧性分析這些胎兒的病歷資料及圍產結跼.新生兒存活≥42 d者(38例)作為存活組,新生兒存活不足42 d者(11例)作為死亡組.採用t檢驗、x2檢驗、Fisher精確概率法及Logistic迴歸模型分析預後不良的影響因素. 結果 (1)產前超聲診斷“雙泡徵”胎兒羊水過多髮生率為88%(50/57),胎死宮內髮生率為4%(2/57),閤併畸形髮生率為23%(13/57).8例引產終止妊娠,其餘49例活產分娩.49例活產新生兒中10例放棄治療,另外39例接受手術治療,1例術後死亡,其餘38例存活≥42 d.生後42 d總體存活率為67%(38/57),手術存活率為97%(38/39).(2)死亡組新生兒的齣生胎齡和齣生體重分彆為(35.8±3.0)週和(2 229±567)g,均小于存活組新生兒[分彆為(38.1±1.9)週和(2 830±558)g,f值分彆為2.859和3.136,P值均<0.01].死亡組新生兒產前診斷閤併畸形髮生率及生後診斷染色體異常髮生率均為3、11,均高于存活組新生兒[均為3%(1/38),P值均<0.05].(3)“雙泡徵”胎兒閤併FGR時,閤併畸形的風險較高(OR=9.893, 95%CI:1.758~55.661,P=0.009). 結論 “雙泡徵”胎兒髮生早產、低齣生體重、閤併畸形和染色體異常者預後不良.
목적 탐토산전초성현시복부“쌍포정”태인적위산결국급영향기예후적인소.방법 2000년1월1일지201 3년12월31일,57례잉부우상해교통대학의학원부속신화의원산전초성검사진단태인“쌍포정”,회고성분석저사태인적병력자료급위산결국.신생인존활≥42 d자(38례)작위존활조,신생인존활불족42 d자(11례)작위사망조.채용t검험、x2검험、Fisher정학개솔법급Logistic회귀모형분석예후불량적영향인소. 결과 (1)산전초성진단“쌍포정”태인양수과다발생솔위88%(50/57),태사궁내발생솔위4%(2/57),합병기형발생솔위23%(13/57).8례인산종지임신,기여49례활산분면.49례활산신생인중10례방기치료,령외39례접수수술치료,1례술후사망,기여38례존활≥42 d.생후42 d총체존활솔위67%(38/57),수술존활솔위97%(38/39).(2)사망조신생인적출생태령화출생체중분별위(35.8±3.0)주화(2 229±567)g,균소우존활조신생인[분별위(38.1±1.9)주화(2 830±558)g,f치분별위2.859화3.136,P치균<0.01].사망조신생인산전진단합병기형발생솔급생후진단염색체이상발생솔균위3、11,균고우존활조신생인[균위3%(1/38),P치균<0.05].(3)“쌍포정”태인합병FGR시,합병기형적풍험교고(OR=9.893, 95%CI:1.758~55.661,P=0.009). 결론 “쌍포정”태인발생조산、저출생체중、합병기형화염색체이상자예후불량.
Objective To determine the perinatal outcomes and its risk factors of fetuses prenatally diagnosed with the double bubble sign on ultrasound scanning.Methods The clinical data of 57 cases of fetal double bubble sign which was prenatally diagnosed by ultrasound in Xin Hua Hospital from January 1,2000 to December 31,2013 were retrospectively analyzed.The neonates survived not less than 42 days were as surviving group,and who survived lower than 42 days were as dead group.The t test,x2 test and Logistic regression were used for statistical analysis of the data.Results Of 57 fetuses with the double bubble sign,the incidence of polyhydramnios,intrauterine fetal death and associated anomalies was 88% (50/57),4% (2/57) and 23% (13/57),respectively.Induced labor to terminate the pregnancy was occurred in eight cases,the other 49 cases had live births but ten neonates abandoned therapy.Thirty-nine live babies accepted surgical treatment with one dead,and the other 38 neonates survived not less than 42 days.The overall 42-day survival rate was 67% (38/57) and the surgical survival rate was 97% (38/39).Compared with surviving neonates,the neonates who died had lower gestational age [(35.8±3.0) vs (38.1 ± 1.9) weeks,t=2.859,P<0.01] and birth weight [(2 229±567) vs (2 830±558) g,t=3.136,P<0.01],and a higher incidence of prenatally diagnosed structural anomalies [3/11 vs 3% (1/38),P<0.05] and karyotype anomalies detected after birth [3/11 vs 3% (1/38),P<0.05].Logistic regression analysis showed that the fetuses with the double bubble sign and fetal growth restriction had a higher risk of complications (OR=9.893,95%CI:1.758 55.661,P=0.009).Conclusions Fetuses with double bubble sign have adverse outcome if they complicating preterm delivery,low birth weight,prenatally diagnosed structural anomalies and karyotype anomalies.